Search


Swissmedic Guidance: Renewal, Discontinuation, and Status Change of Medicinal Product Authorizations
The Swiss Agency for Therapeutic Products (Swissmedic)Â has released an updated guidance, " Renewal, Discontinuation, and Status Change of...

Sharan Murugan
Mar 32 min read
22 views
0 comments


Swissmedic Guidance: Submission of PSUR/PBRER Submission for Human Medicinal Products
The Swiss Agency for Therapeutic Products (Swissmedic)Â has released an updated guidance" Submission of Periodic Safety Update Reports...

Sharan Murugan
Mar 32 min read
31 views
0 comments


India CDSCO: Adding Trial Sites and Changing Principal Investigators
Clinical trials are a cornerstone of medical advancement, requiring meticulous planning and adherence to regulatory guidelines. In India,...

Sharan Murugan
Mar 33 min read
9 views
0 comments


EMA Procedural Advice: Appointment of CHMP, CAT, and PRAC Rapporteurs and Co-Rapporteurs
The European Medicines Agency (EMA)Â has released an updated procedural guidance document on the " Appointment of CHMP, CAT, and PRAC...

Sharan Murugan
Mar 12 min read
29 views
0 comments


MHRA Guidance: Format and Content of Applications for Agreement or Modification of a Paediatric Investigation Plan
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has established comprehensive guidelines detailing the " Format and...

Sharan Murugan
Feb 282 min read
24 views
0 comments


EMA Addendum: Clinical Development of Vaccines in Immunocompromised Individuals
The European Medicines Agency (EMA) has released an addendum to its Guideline on the " Clinical Development of Vaccines to address the...

Sharan Murugan
Feb 272 min read
11 views
0 comments


FDA Philippines: Draft Guidelines for Registration of Chemical and Biological Pharmaceutical Products
The Food and Drug Administration (FDA) of the Philippines has recently published draft guidelines to streamline the registration process...

Sharan Murugan
Feb 222 min read
22 views
0 comments


SAHPRA South Africa: Renewal of the Certificate of Registration - Fee Schedule and Explanatory Notes
The South African Health Products Regulatory Authority (SAHPRA)Â has updated its " Fee Schedule and Explanatory Notes " Â to renew human...

Sharan Murugan
Feb 192 min read
16 views
0 comments


South Africa's SAHPRA: Renewal Process for Human -A Comprehensive Guide
The South African Health Products Regulatory Authority (SAHPRA) is responsible for monitoring, evaluating, and regulating the renewal of...

Sharan Murugan
Feb 122 min read
42 views
0 comments


UK MHRA Guidance: Managing Clinical Trial Authorisations & Safety Reporting (Updated 2025)
The UK Medicines and Healthcare products Regulatory Agency (MHRA)Â has updated its guidance on " Clinical trials for medicines: manage...

Sharan Murugan
Feb 92 min read
77 views
0 comments


UK MHRA Guidance: Exceptions and Modifications to the EU Good Pharmacovigilance Practices (GVP) for UK MAHs
The Medicines and Healthcare Products Regulatory Agency (MHRA) has released updated guidance on pharmacovigilance requirements that...

Sharan Murugan
Feb 82 min read
63 views
0 comments


UK MHRA Draft Guideline: Individualised mRNA Cancer Immunotherapies
The Medicines and Healthcare products Regulatory Agency (MHRA) has recently initiated a public consultation on draft guidance for "...

Sharan Murugan
Feb 52 min read
12 views
0 comments


USFDA Guidance: Institutional Review Board (IRB) Written Procedures
Institutional Review Boards (IRBs) play a crucial role in safeguarding the rights and welfare of human research subjects. To enhance...

Sharan Murugan
Feb 52 min read
8 views
0 comments


USFDA Guidance: Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis and Reduce the Risk of Transmission of Mycobacterium tuberculosis
The U.S. Food and Drug Administration (USFDA) has released two important guidance documents addressing the risks of sepsis and...

Sharan Murugan
Feb 13 min read
19 views
0 comments


UK MHRA Guidance: Regulatory Framework for Licensing, Importing, and Supplying Medicines in the UK
The UK Medicines and Healthcare Products Regulatory Agency (MHRA)Â has issued several guidance documents detailing the licensing,...

Sharan Murugan
Feb 13 min read
41 views
0 comments


South Africs's SAHPRA Communication: Regulatory Information Management System – Application Withdrawal
The South African Health Products Regulatory Authority (SAHPRA)Â has issued a Communication to the industry on the process for the...

Sharan Murugan
Jan 262 min read
18 views
0 comments


Malaysia’s NPRA: Drug Registration Guidance Document (DRGD), 3rd Edition, Ninth Revision January 2025
Malaysia’s Drug Registration Guidance Document (DRGD) is a cornerstone for pharmaceutical compliance. The " Drug Registration Guidance...

Sharan Murugan
Jan 262 min read
69 views
0 comments


Health Canada: Validation Rules for Regulatory Transactions in eCTD and Non-eCTD Formats
Health Canada has released detailed guidances addressing the validation rules for regulatory transactions submitted in two formats: "...

Sharan Murugan
Jan 263 min read
50 views
0 comments


EMA Guidance: Procedural Advice for Orphan Medicinal Product Designation
The European Medicines Agency (EMA) provided detailed revised guidance "Procedural Advice for Orphan Medicinal Product Designation " for...

Sharan Murugan
Jan 262 min read
7 views
0 comments


Swissmedic Guidance: Orphan Drug Designation (ODS)
Swissmedic has published an updated guidance for" Orphan Drug " aimed at streamlining the regulatory process for medicinal products...

Sharan Murugan
Jan 192 min read
23 views
0 comments